Standout Papers

Ferroptosis heterogeneity in triple-negative breast cancer reveals an in... 2020 2026 2022 2024341
  1. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy (2022)
    Fan Yang, Yi Xiao et al. Cell Metabolism
  2. Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets (2020)
    Yue Gong, Peng Ji et al. Cell Metabolism
  3. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer (2022)
    Hai Wang, Xingyu Rong et al. Cell Metabolism
  4. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer (2022)
    Yi Xiao, Ding Ma et al. Cell Research

Immediate Impact

6 by Nobel laureates 22 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

A high-fat diet promotes cancer progression by inducing gut microbiota–mediated leucine production and PMN-MDSC differentiation
2024 Standout
Emergence of large-scale cell death through ferroptotic trigger waves
2024 StandoutNature
1 intermediate paper

Works of Da‐Qiang Li being referenced

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
2022 Standout
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
2022 Standout

Author Peers

Author Last Decade Papers Cites
Da‐Qiang Li 3011 1072 1169 85 4.3k
Kazuya Shinmura 3016 1145 1096 139 4.5k
Kathleen Kelly 3573 1203 878 87 5.8k
Chunhong Yan 2954 1092 1332 103 4.7k
Juliane M. Jürgensmeier 3683 1236 729 67 5.3k
Xin Liu 3402 1145 1049 102 5.3k
Kazuhiko Tanzawa 3041 1660 2158 60 6.5k
Michael Peyton 3482 1437 741 54 5.7k
Claudio Festuccia 2777 1589 1068 163 5.2k
Eugenio Erba 2118 1243 787 138 4.6k
Zhi‐Qiang Xiao 2557 910 1019 160 3.6k

All Works

Loading papers...

Rankless by CCL
2026